- Melatonin has genuine, peer-reviewed evidence supporting modest improvements in sleep onset and overall sleep quality — particularly for circadian-rhythm disruptions like jet lag and shift work.
- Effects on sleep quality in people with primary insomnia are real but modest; melatonin is not a sedative and works best when your body clock is misaligned, not simply when you're stressed or anxious.
- Low doses (0.5–3 mg) taken 30–60 minutes before your target bedtime appear as effective as higher doses, with fewer next-day side effects.
- Melatonin is generally considered safe for short-term use in healthy adults; long-term safety data, and safety in pregnancy, remain limited.
What the evidence shows
Melatonin is one of the better-studied sleep supplements, which doesn't mean the evidence is uniformly strong — but it does mean we have enough data to say something meaningful.
For jet lag and circadian misalignment, the case is clearest. A Cochrane review of ten randomized controlled trials found melatonin was remarkably effective at reducing jet-lag symptoms when taken at the destination's local bedtime after crossing five or more time zones (Herxheimer & Petrie, 2002). This is the use case where melatonin's biology fits the problem most directly.
For primary insomnia (trouble sleeping without an identifiable circadian cause), a 2013 meta-analysis of 19 RCTs found melatonin significantly reduced sleep-onset latency by about 7 minutes and improved overall sleep quality ratings, though the effect sizes were modest (Ferracioli-Oda et al., 2013). A separate meta-analysis confirmed similar findings, noting that effects were more consistent for sleep quality ratings than for total sleep time (Liu et al., 2012). Seven minutes sounds underwhelming, but if you're lying awake for 45 minutes, it's a real reduction.
For shift workers, evidence is mixed. Some trials show improved daytime sleep duration; others show minimal benefit, likely because irregular schedules make consistent dosing timing difficult (Liira et al., 2014).
For older adults, who naturally produce less melatonin, there is some evidence of benefit. A placebo-controlled trial in adults over 55 found prolonged-release melatonin (2 mg) improved sleep quality and morning alertness compared to placebo (Wade et al., 2007). The European Medicines Agency has approved this formulation for short-term use in that age group.
What melatonin does not have good evidence for: treating anxiety-driven insomnia, improving sleep quality in young healthy adults without circadian disruption, or replacing cognitive behavioral therapy for insomnia (CBT-I), which remains the first-line treatment recommended by sleep medicine guidelines.
How it works (mechanism)
Melatonin is a hormone produced by the pineal gland in response to darkness. It doesn't knock you out the way a sedative does — it signals to your brain and body that night has arrived, shifting your circadian clock and slightly lowering core body temperature to facilitate sleep onset. Receptors in the suprachiasmatic nucleus (the brain's master clock) and peripheral tissues respond to melatonin to coordinate the timing of sleep (Pandi-Perumal et al., 2008). Because it's a timing signal rather than a sedative, taking it at the wrong clock time reduces its usefulness — this is why dose timing matters as much as dose size.
Dose & timing if you try it
Most people dramatically over-dose melatonin. Supplements in the U.S. commonly come in 5–10 mg doses, but research suggests 0.5–3 mg is the physiologically relevant range for most adults (Brzezinski et al., 2005). Higher doses don't produce proportionally better sleep and can leave next-day grogginess or blunted response over time.
- For sleep onset difficulty: 0.5–3 mg taken 30–60 minutes before your desired sleep time.
- For jet lag (eastward travel): Take 0.5–3 mg at destination bedtime for 3–5 nights. Starting the night of arrival is reasonable for most people.
- Prolonged-release formulations (2 mg): May be preferable for older adults who wake during the night, as the slow release better mimics natural melatonin patterns.
- Light hygiene matters: Melatonin works poorly if you're looking at bright screens after taking it — blue light suppresses endogenous melatonin and may blunt the supplement's signal.
Note that supplement melatonin is not regulated as a drug in the U.S., and independent testing has found wide variability in actual dose content — from 83% to 478% of the labeled dose in one analysis (Erland & Saxena, 2017). Buying from manufacturers who use third-party testing (USP, NSF, or Informed Sport certification) reduces this variability.
Who should skip
- Pregnant or breastfeeding individuals: Safety data are insufficient. Melatonin crosses the placenta and is present in breast milk; its effects on fetal and infant development are not adequately studied. Avoid unless under direct medical supervision.
- Children and adolescents: Use only under pediatric guidance. Some evidence supports melatonin in children with neurodevelopmental conditions (e.g., ADHD, autism spectrum disorder), but routine use in neurotypical children is not well-supported and long-term effects on puberty timing are unclear.
- People on anticoagulants (warfarin): Melatonin may enhance anticoagulant effects; monitoring is warranted.
- People on immunosuppressants: Melatonin has immunomodulatory properties and may interact with cyclosporine and similar drugs.
- People with autoimmune conditions: The immunostimulatory potential of melatonin raises theoretical concerns; discuss with your physician.
- Anyone with chronic insomnia as the primary diagnosis: CBT-I, not melatonin, is the evidence-based first-line treatment. Melatonin may complement it but shouldn't replace it.
Bottom line
Melatonin earns its reputation for jet lag and circadian-rhythm disruption — the evidence there is solid. For general sleep quality in adults with primary insomnia, it offers modest, real, but unremarkable improvements in sleep onset and perceived sleep quality. It is not a sedative, not a cure for insomnia, and not a substitute for good sleep hygiene or CBT-I. If your sleep problem stems from a misaligned body clock, melatonin is a reasonable, low-risk tool at low doses. If your problem is stress, anxiety, or chronic insomnia, the evidence strongly favors behavioral approaches over any supplement. As always, if sleep problems persist beyond a few weeks, a clinician visit beats a supplement aisle.
References
- Brzezinski, A., et al. (2005). Effects of exogenous melatonin on sleep: A meta-analysis. Sleep Medicine Reviews, 9(1), 41–50.
- Erland, L. A. E., & Saxena, P. K. (2017). Melatonin natural health products and supplements: Presence of serotonin and significant variability of melatonin content. Journal of Clinical Sleep Medicine, 13(2), 275–281.
- Ferracioli-Oda, E., Qawasmi, A., & Bloch, M. H. (2013). Meta-analysis: Melatonin for the treatment of primary sleep disorders. PLOS ONE, 8(5), e63773.
- Herxheimer, A., & Petrie, K. J. (2002). Melatonin for the prevention and treatment of jet lag. Cochrane Database of Systematic Reviews, Issue 2, CD001520.
- Liira, J., et al. (2014). Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. Cochrane Database of Systematic Reviews, Issue 8, CD009776.
- Liu, J., et al. (2012). Melatonin for the treatment of insomnia: A systematic review and meta-analysis. Journal of Psychiatric Research, 46(9), 1223–1230.
- Pandi-Perumal, S. R., et al. (2008). Melatonin: Nature's most versatile biological signal? FEBS Journal, 273(13), 2813–2838.
- Wade, A. G., et al. (2007). Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years. Current Medical Research and Opinion, 23(10), 2597–2605.